Showing 1 - 8 results of 8 for search 'Nina Kohn', query time: 0.04s
Refine Results
-
1
A Real-World Comparison of Drug Trough Levels between Patients Experiencing a Secondary Nonimmune Loss of Response and Those Maintaining a Response to Infliximab on Long-Term Maint... by Michael Farber, Jeremy Polman, Nina Kohn, Vincent Chua, Arun Swaminath, Keith Sultan
Published 2024-09-01
Article -
2
-
3
The Impact of Surgical Delay: A Single Institutional Experience at the Epicenter of the COVID Pandemic Treatment Delays in Women with Endometrial Cancer and Endometrial Intraepithe... by Kieran Seay, Arielle Katcher, Maia Hare, Nina Kohn, Hannah Juhel, Gary L. Goldberg, Marina Frimer
Published 2023-12-01
Article -
4
-
5
Efficacy of ketamine mouthwash in the management of oral and pharyngeal toxicity associated with head and neck chemoradiotherapy: protocol for a phase II, Simon’s two-stage trial by Nagashree Seetharamu, Diana Martins-Welch, Nina Kohn, Joseph Herman, Daniel Koffler, Jacob Eckstein, Maged Ghaly, Louis Potters, Douglas Frank, Kevin Sullivan, Bhupesh Parashar
Published 2023-04-01
Article -
6
Incidence of Acute Kidney Injury in Patients with Chronic Renal Insufficiency: Transcatheter versus Surgical Aortic Valve Replacement by Michael Catalano, Dishen Lin, Hugh Cassiere, Nina Kohn, Bruce Rutkin, Greg Maurer, Jacinda A. Berg, Jaclyn Jahn, Rick Esposito, Alan Hartman, Pey-Jen Yu
Published 2019-01-01
Article -
7
Evaluating of HPV–DNA ISH as an adjunct to p16 testing in oropharyngeal cancer by Jeffrey Chi, Isabel R Preeshagul, Silvat Sheikh-Fayyaz, Sewit Teckie, Nina Kohn, Yonah Ziemba, Alice Laser, Douglas Frank, Maged Ghaly, Dev Kamdar, Dennis Kraus, Doru Paul, Nagashree Seetharamu
Published 2020-10-01
Article -
8
Validation of the IMPROVE‐DD risk assessment model for venous thromboembolism among hospitalized patients with COVID‐19 by Alex C. Spyropoulos, Stuart L. Cohen, Eugenia Gianos, Nina Kohn, Dimitrios Giannis, Saurav Chatterjee, Mark Goldin, Marty Lesser, Kevin Coppa, Jamie S. Hirsch, Thomas McGinn, Matthew A. Barish, the COVID‐19 Consortium Group
Published 2021-02-01
Article